Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [2291]

The EMA perspective on drug approval process in the era of precision medicine

Jorge Camarero - Spanish Agency of Medicines and Medical Services, Spain

The EMA perspective on drug approval process in the era of precision medicine ( Jorge Camarero - Spanish Agency of Medicines and Medical Services, Spain )

Liquid biopsy in daily clinical practice

Prof Klaus Pantel - University of Hamburg, Hamburg, Germany

Liquid biopsy in daily clinical practice ( Prof Klaus Pantel - University of Hamburg, Hamburg, Germany )

Clinical trials in the era of genomic medicine

Prof Filippo de Braud - University of Milan, Milan, Italy

Clinical trials in the era of genomic medicine ( Prof Filippo de Braud - University of Milan, Milan, Italy )

Complexity of computational analysis of genome sequencing and reporting

Dean Pavlick - Foundation Medicine Inc., Cambridge, USA

Complexity of computational analysis of genome sequencing and reporting ( Dean Pavlick - Foundation Medicine Inc., Cambridge, USA )

Milan summit on precision medicine

Prof Chiara Tonelli - University of Milan, Milan, Italy

Milan summit on precision medicine ( Prof Chiara Tonelli - University of Milan, Milan, Italy )

Unknown primary and rare cancers

Prof Alwin Krämer - German Cancer Research Center, Heidelberg, Germany

Unknown primary and rare cancers ( Prof Alwin Krämer - German Cancer Research Center, Heidelberg, Germany )

Lung cancer and precision medicine

Dr Pilar Garrido - Universidad de Alcalá, Madrid, Spain

Lung cancer and precision medicine ( Dr Pilar Garrido - Universidad de Alcalá, Madrid, Spain )

Challenges of personalised oncology

Prof Pier Guiseppe Pelicci - European Institute of Oncology, Milan, Italy

Challenges of personalised oncology ( Prof Pier Guiseppe Pelicci - European Institute of Oncology, Milan, Italy )

Clinical validity of NGS and innovation in clinical diagnosis

Dr Jeffrey Ross - Albany Medical College, Albany, USA

Clinical validity of NGS and innovation in clinical diagnosis ( Dr Jeffrey Ross - Albany Medical College, Albany, USA )

VinCaP: A phase II trial of vinflunine chemotherapy in locally-advanced and...

Dr Lisa Pickering - The Royal Marsden NHS Foundation Trust, London, UK

VinCaP: A phase II trial of vinflunine chemotherapy in locally-advanced and metastatic carcinoma of the penis ( Dr Lisa Pickering - The Royal Marsden NHS Foundation Trust, London, UK )

Tumour fraction in circulating free DNA as a biomarker of disease dynamics in...

Dr Atish Choudhury - Dana-Farber Cancer Institute, Boston, USA

$Tumour fraction in circulating free DNA as a biomarker of disease dynamics in metastatic prostate cancer ( Dr Atish Choudhury - Dana-Farber Cancer Institute, Boston, USA )$

Crizotinib for advanced papillary renal cell carcinoma with MET mutations or...

Prof Patrick Schöffski - The Katholieke Universiteit Leuven, Leuven, Belgium

Crizotinib for advanced papillary renal cell carcinoma with MET mutations or amplification ( Prof Patrick Schöffski - The Katholieke Universiteit Leuven, Leuven, Belgium )

More from ecancer